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Abstract 
OBJECTIVE: To assess determinants of the participation rate in breast cancer screening (BCS) pro-
grams by conducting a systematic review of reviews. 
METHODS: We conducted a systematic search in Pubmed via Medline, Scopus, Embase, and 
Cochrane identifying the literature up to April 2019.  Out of 2,258 revealed unique abstracts, we in-
cluded 31 reviews from which 25 were considered as systematic.  We applied the Walsh & McPhee 
Systems Model of Clinical Preventive Care to systematise the determinants of screening participation.  
RESULTS: The reviews, mainly in high-income settings, reported a wide range for BCS participation 
rate: 16-90%. The determinants of BCS participation were simple low-cost interventions, such as in-
vitation letters, basic information on screening, multiple reminders, fixed appointments, prompts from 
healthcare professionals, and healthcare organizational factors (eg. close proximity to screening facil-
ity). More complex interventions (such as face-to-face counselling or home visits), mass media or im-
proved access to transport should not be encouraged by policy makers unless other information ap-
pears. The repeated participation in mammography screening was consistently high, above 62%. Pre-
vious positive experience with screening influenced the repeated participation in screening programs. 
The reviews were inconsistent in the use of terminology related to BCS participation, which may have 
contributed to the heterogeneity in the reported outcomes.    
CONCLUSIONS:  This study shows that consistent findings of systematic reviews bring more cer-
tainty into the conclusions on effects of simple invitation techniques, fixed appointments and prompts, 
as well as healthcare organizational factors on promoting participation rate in screening mammogra-
phy.  
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Background  
A recent meta-analysis of randomized controlled trials showed that an increase in 1% of the participa-
tion rate in screening mammography led to a statistically significant 3% reduction in advanced stage 
and death from breast cancer 1. Furthermore, high participation influences program efficiency because 
the resources invested to launch and maintain a screening program may not be justified if the screening 
is not acceptable to the target population groups. Thus, participation in breast cancer screening (BCS) 
has been recently gaining significant importance in the evaluation and implementation of organized 
screening programs. 
Participation in screening programs can be partially explained by behavioral theories targeting to un-
derstand and amend human behaviors. Many of these theories limit the scope of promotion strategies 
to individual cognition, ignoring environmental or economic factors that may influence a person's in-
tention to participate in screening 2. Alternatively, several planning models with a focus on socio-eco-
logical factors and health systems have been applied in promoting BCS. Among them, Walsh and 
McPhees Systems Model of Clinical Preventive Care 3 was purposely developed to be broad enough 
to encompass different preventive activities.  
Walsh & McPhees Systems Model is a comprehensive theoretical framework structuring the determi-
nants of preventive health behavioral changes with a focus on patient-physician interaction.  Both the 
patient and the physician contribute to the development of preventive behavior while each entity sepa-
rately is influenced by a set of predisposing (eg. sociodemographics, beliefs), enabling (eg. abilities), 
and reinforcing (eg. rewards) factors. In addition, external factors influence preventive behavior, such 
as healthcare delivery (i.e. access to care), preventive (i.e. characteristics of the preventive activity it-
self), and situational (i.e. triggers to health behavior) factors. Walsh & McPhees Systems Model con-
tains components of behavioral, communication, health education, and psychosocial theories and has 
been applied successfully to explain behavior in multiple preventive programs including cancer screen-
ing 46 .  
We apply the Walsh & McPhee Systems Model in structuring the overview of the reviews. The research 
design aims to advise decision-makers on the best evidence they need in the pool of multiple available 
systematic reviews. While systematic reviews of original evidence are focused on narrow well-defined 
questions, a review of reviews allows using higher quality evidence, leading to better decision making 
by critically appraising and combining the results of different secondary analyses. No study, to our 
knowledge, has ever analyzed the results from systematic reviews on participation in BCS programs 
among the general population. Therefore, the primary purpose of this review is to provide a broad syn-
thesis of contributing factors to participation rates in BCS via mammography under the theoretical 
framework described. The secondary objective of the review is to evaluate the quality of the systematic 
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reviews reporting participation rates in BCS programs and the degree of consistency in the terminology 
being used. 
Methods 
Design and search strategy 
The design of this study was reported in the published protocol 7, registered in PROSPERO 
(CRD42016050764). We searched systematically the databases Pubmed via Medline, Scopus, Embase, 
and Cochrane, and the grey literature (Appendix A) with the last update in May 2019. The search line 
developed for Pubmed and adapted for the other databases was modified from the search strategy of 
Bonfill et al. (2001) 8 (the details are presented in Appendix A). In our review, we included reviews 
from commencement until the search date on mammography screening or multiple BCS approaches 
including mammography screening as one of the target interventions among the general population.  
Search Outcomes 
Participation rate in BCS, the primary outcome of the study, was defined as the number of women who 
have a screening test as a proportion of all women who are invited to attend for screening 9. This defi-
nition was mainly referred to as participation or uptake in the literature 911.  A secondary outcome 
that we used was attendance or coverage. Coverage is defined by the European Guidelines for Quality 
Assurance in Breast Cancer Screening and Diagnosis as the percentage of the target population under-
going screening 9. Since coverage represents availability of screening rather than preferences, we report 
it as a secondary outcome, aiming to compare the terminologies and definitions applied in the system-
atic reviews on BCS.  
Considering opacity in definitions used in secondary analyses of evidence, we pre-established the fol-
lowing terminology to summarise the reviews findings: 
Participation rate - when talking about reviews of studies of any design when it is defined as so, and for 
the reviews of all randomised controlled trials, controlled trials, and quasi-experimental designs without 
definition. 
Attendance rate - when talking about reviews of studies of any design when using the definition of 
coverage or an equivalent, and for all results from mixed or observational studies without definition. 
To assess the factors contributing to the participation rate, we applied the Walsh & McPhee Systems 
Model of Clinical Preventive Care 3. Specifically, we grouped the factors identified as predisposing, 
enabling, reinforcing, organizational, situational, and preventive. 
Data extraction and synthesis 
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Both abstracts and full texts were screened in duplicate. All the data were extracted using a pre-tested 
data extraction form with single-entry by the first author (OM) and verified by a second reviewer (NZ, 
FM, COR, JS or RM). If the participation rate was not reported, we attempted to calculate it from the 
reviews or summaries of the original data. Considering high heterogeneity in methods and outcomes, 
we applied structured qualitative synthesis.  
Quality assessment  
Two authors assessed independently the quality of the reviews with the Assessing the Methodological 
Quality of Systematic Reviews (AMSTAR) checklist 12, solving any disagreements by consensus. Be-
cause discriminating the reviews outcomes by quality may lead to biased conclusions, we included all 
the reviews independently on their quality score.  Meanwhile, we excluded from summaries the reviews 
scored two or less on AMSTAR, considering them as non-systematic.  
Results 
We identified 2,161 abstracts through systematic and 316 more through non-systematic search, result-
ing in 31 included reviews (Figure 1), of which 25 were considered systematic. The inter-rater reliability 
between the two reviewers for the decisions on full-texts inclusion was 85% (Cohen's kappa = 0.63, 
substantial agreement). Though the search was not limited to English-language publications, we ex-
cluded one of the reviews based on this criterion deviating from the protocol (Appendix B). The char-
acteristics of the included reviews are presented in Appendix C.  
[Figure 1 near here] 
The systematic reviews had a broad geographic perspective (Appendix C), with some of them aiming 
to identify an evidence relevant for either specific countries (USA, the UK, France, Canada, or Japan) 
1320, geographic regions 1, or populations by income or ethnicity 2124.  Most of the reviews focused on 
interventions to improve participation rate (14) or behavior of screened population and associated fac-
tors (12). The majority of reviews were publicly funded and no reviews reported a private source of 
funding (Appendix C).   
We did not find any difference in the conclusions of the reviews based on their AMSTAR score, date 
of search or date of publication.  The AMSTAR quality criteria that were the least frequently fulfilled 
(Figure 2) were those related to reporting the excluded studies (8 or 26% of the reviews), formulating 
conclusions on the basis of the scientific quality of the included studies (7 or 23%), assessing the like-
lihood of publication bias (6 or 19%) and reporting conflict of interest for the included studies (one 
study). Other limitations of the reviews included a lack of clarity on the first or successive calls for 
screening uptake, geographical origin of the included original evidence, and weaknesses in methodo-
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logic designs of original studies (Appendix D). Only 22 out of the 31 reviews were at least mention-
ing the limitations of the original studies. These included lack of theory use 24, quality of methodol-
ogy/design 1,1518,20,2427,  poor reporting of the methods or terminology 19,20,28, ethical issues 18, and 
limited generalizability particularly since very few studies were conducted outside of the USA 29 
(Appendix D).   
[Figure 2 near here] 
 
Participation in mammography screening 
BCS attendance within short timeframe (<5 years) ranged 15 - 92% in systematic and 1 - 92% in all 
the reviews; the participation rate was 6 - 90% in systematic and narrative reviews and 40-90% 
among the women invited to screening in the reviews of randomized controlled trials exploring breast 
cancer mortality decrease with mammography screening (Appendix E). Only one review based on 
randomized trials defined the target outcomes as number of attendees divided by the number of in-
vitees; this review showed less variable participation range (61-90%) 1.   
Secondary attendance to mammography screening (re-attendance) was consistently high, above 62% 
in four reviews 15,16,28,30. Non-attenders of the first visit had a much lower attendance rate after re-
minders were sent to them than in the cohort of women who responded positively to their first screen-
ing invitation (4-42% vs. 46-86%) 13.  The re-attendance was higher with biennial than annual screen-
ing in the review by Vernon et al (2010) 28, and was lower among those women who previously expe-
rienced pain during mammography according to Whelehan et al (2013), though these results were not 
statistically significant 30.  
Overall, the reviews were inconsistent regarding the terminology or the definitions of the outcomes: 
some reviews did not define the outcomes used, whereas others combined in one synthesis coverage 
and participation rates (Appendix E). 
Participation in other BCS programs 
Only a few reviews reported population preferences for other BCS approaches. A narrative review re-
ported a participation rate in clinical breast examination ranging between 13 and 70% among women 
in Arabic countries 31, while another one reported 31 to 72% 27. However, the outcomes in both re-
views were not clearly defined.  No reviews reported participation rates when using BCS ultrasonog-
raphy.  
Regional variabilities in BCS participation and attendance  
The reviews included studies mainly from high-income Western or North American countries. Most 
of the evidence was coming from the USA (Appendix C), with three reviews being able to identify 
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studies only from this country 22,25,26. A few reviews targeting Asian populations 1,17,24 included Euro-
pean and North American trials and therefore did not detect regional variabilities. While there is no 
sufficient data describing regional differences, Brewer et al. (2007) 16 and Bhargava et al. (2018) 23 
reported variability in geographical regions (Appendix E) 16,23; for instance, re-attendance rate was 
higher in Western Europe: 71-94% versus 57-81% in the USA or 49-74% in Canada 16. Few reviews 
included information on low- and middle-income countries (Chile, South Africa, Brazil, Thailand, and 
Mexico) 21,32 and reported only generalized data. Therefore, it is difficult to make any definitive con-
clusions regarding the outcomes in such settings. 
Factors contributing to variability in BCS participation and attendance 
We examined the impact of multiple factors on mammography screening participation, attendance, 
and re-attendance, using the Walsh & McPhee Systems Model (Figure 3) 3. In general, the reviews 
based on randomized trials are more oriented to factors related to program organization and the pro-
cess of invitation, while reviews based on observational studies analyse more contextual factors such 
as demographic and cultural barriers, corresponding to those including countries from regions other 
than North America and Europe (Appendices C, E). 
[Figure 3 near here] 
[Table 1 near here] 
[Table 2 near here] 
 
We summarise factors defining participation and attendance rates where the original and secondary 
evidence was consistent in Table 1, and those with inconsistent effect in Table 2. Overall, the re-
views were inconsistent regarding an impact of patients predisposing factors on getting a future 
screening mammogram, in particular whether other preventive behaviors, medical history, demo-
graphic description or self-beliefs and worries could affect womens decision to attend BCS (Table 2).  
For instance, the reviews were inconsistent as to whether higher uptake rate was associated with 
young age14,15, 24, ethnicity and culture14, 23, 34, or socio-economic factors, defined by deprivation area, 
levels of education, and income14, 15, 21. Jepson et al. (2000) found that high level of education was sig-
nificant only in 17% of studies and population ethnicity in 33% of the studies, with income, religion, 
and language spoken also defined as insignificant variables14. Soler-Michel et al. (2005) discussed 
whether socio-economic characteristics were not important because of heterogeneity in data depend-
ing on jurisdictions included (eg. no impact of socio-economic characteristics in Finland, Italy or 
France)15.  However, the meta-analysis of Damiani et al. (2015)21 found that women with the highest 
level of education were more likely to be screened, even though not every study included reached sig-
nificance on this indicator. In general, the reviews that concluded on questionable impact of socio-
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economic determinants were older (searched before 2003) and relied on both cross-sectional and pro-
spective studies, whereas the positively framed reviews were based on more recent cross-sectional ev-
idence14,15,23,24. 
Intentions to screening was the only consistent patients predisposing factor associated with BCS at-
tendance (Table 1) 14,15.  Physician predisposing factors (demographics, gender, ethnicity, language, 
beliefs, attitudes, prior clinical experience, and personal health practices) were not reported in the 
summarised literature. 
The enabling factors of Walsh & McPhees Systems Model 3 are related to skills and resources neces-
sary to perform the behavior.  In this group, we included the elimination of financial barriers, general 
knowledge of breast cancer risk and BCS, approaches to information and invitation delivery, access to 
screening, and approaches towards education about BCS.   
The reviews agreed on the  importance of financial barriers in patients screening decisions 14,15,22,32, 
while Brouwers et al. (2011) 20 concluded on insufficient evidence to recommend for or against reduc-
ing out-of-pocket costs related to mammography screening 20. The reviews were consistent that sim-
ple active recruitment strategies, such as letters of invitation or phone calls, improve participation (Ta-
ble 1) 8,14,19,22,29,33. While interventions promoted higher participation among ethnic minorities includ-
ing the use of bilingual instructions, and patients handouts or forms 22, tailoring invitations to ethnic-
ity had a negative impact on screening participation 33. Interestingly enough, there was no consistency 
in the reviews on importance of screening knowledge14,15,24; the evidence was unclear  whether tai-
lored invitation interventions in general are more effective than standard ones 18,22.  Nevertheless, the 
reviews agreed that untargeted mass invitations (including social networks and mass media) had no 
effect on screening participation 13,20,34, while recommendations from healthcare providers were im-
portant 14,19,33. 
 
Regarding education-related interventions, the reviews based on both trials and observational evi-
dence showed a positive impact of telephone counselling 8,14,28,29, face-to-face counselling 18,20,22,28, 
and educational home visits 14,29 on uptake of screening mammography. However, the last two types 
of intervention were non-superior to simple calls or letters 8,13,14,33. In addition, three reviews found no 
evidence of a positive effect, and even a negative impact, of very extensive health information on 
screening participation directed toward women of low educational background 13,18,22.    
Physician enabling factors include training, technical expertise, knowledge, and resources 3. Among 
these factors, only physician education was assessed in two reviews, concluding on no or unclear ef-
fect on BCS participation/attendance 14,22. 
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Reinforcing factors of the Walsh & McPhee Systems Model (1992) 3, such as rewards or incentives, 
were limitedly reported in the included literature.  Both patient 14,18,20,34 and provider 20 reinforcing 
factors were not determined as evidently consistent in the reviews.  
The most frequently reported healthcare delivery system organizational factors were logistic, struc-
ture, and management related.  A short distance to facilities (for instance, mobile mammography units 
or community hospitals) could increase access to BCS and ultimately increase participation rates 
14,25,32. Meanwhile, improved logistics, such as access to bus transportation, did not have the same 
strengths of evidence 13,15. 
In terms of preventive activity factors, the reviews showed that they were related to previous positive 
or negative experiences of mammography 14-16,30.  Women who had a positive experience indicated an 
improved re-attendance 15, while those who experienced pain during the past mammography and a re-
lated anxiety had a lower attendance rate 15,30.  The direction of effect of previous false-positive results 
of mammographic screening on attendance rate in subsequent screenings is not straightforward and 
consistent between different geographic regions as shown in the review by Brewer et al. (2007) 16. 
Finally, in regard to the situational factors and cues to action, fixed appointment with any invitation 
approach 13,14,18,22 as well as mailed patient reminders 8,13,14,1819,22,28 were reported as highly effective 
to increase participation. Curbow et al. (2004) 34 also commented on the potential effectiveness of sec-
ond mailed reminders. Similarly, providers prompts or reminders were considered to be effective 
14,18,19,28 . 
On the other hand, insufficient evidence was reported on clear differences among the different re-
minder strategies (for example, between a face-to-face reminder and a telephone call) 18,20, and there 
were conflicting conclusions in proposing convenient appointment scheduling for women invited to 
screening 15,22.  In addition, reviews showed that risk-factor questionnaires had no effect on BCS 14,26. 
Discussion 
Our review of reviews highlighted several important issues. Firstly, it identified factors with a con-
sistent impact on BCS participation rate, allowing policy makers to focus on interventions with little 
or no uncertainty regarding a positive impact. For women invited to screening for the first time, such 
interventions with a positive effect include: 
x Removal of financial barriers  
x Simple invitation approaches (eg. invitation letter) 
x Healthcare providers recommendations 
x Organizational factors related to healthcare system delivery  
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x Fixed appointments 
x Reminders and providers prompts. 
Since re-attendance of women is affected by womens previous screening experience, screening pro-
viders may use the observed relief effect (more positive perception of screening shortly after the pro-
cedure)36 to address any distress related to mammography screening immediately after the procedure 
in order to improve long-term memories on BCS.  
Secondly, our review demonstrated a possible inconsistency in the reviews conclusions, putting into 
question the a-priori perception of the reviews as a lens of evidence in the hierarchy of the pyramid 
of evidence. The findings of the different reviews vary depending on the study type (eg. intervention 
vs observational), the country where the evidence was obtained, type of data synthesis approach 
(qualitative or quantitative), and the year limits in the search strategy.  Our review found inconsistent 
results regarding socioeconomic conditions as a determinant of participation in BCS, possibly due to 
the types of studies included in the reviews, years of search, and data analysis applied.  Indeed, some 
population-based research demonstrates a link between socio-economic characteristics and cancer dis-
parities 37,38,39,40, as well as screening participation and deprivation 41.  However, a recent pooled 
cross-sectional time series analysis of 17 European countries with established organised BCS pro-
grams did not find an association between participation rate in BCS and socio-economic characteris-
tics42. This study supports our observations on geographic differences in screening outcomes. Moreo-
ver, it emphasizes that certain questions specific to the context of geographical jurisdictions (e.g. rela-
tionships between socio-economic variables and participation rate) should be informed not only by 
the pooled summaries but also by the national statistical data. Intervention studies show that removal 
of health system and financial barriers is positively associated with participation, and cancer dispari-
ties being reduced through organized screening 42-45, though these efforts are not equally effective in 
all the jurisdictions. 
Thirdly, by looking at disagreements between the reviews our study identified the areas with possibly 
a high value of information. Ambiguity exists in relationships between the BCS participation rate and 
demographic characteristics of the population, knowledge of breast cancer and screening, face-to-face 
counselling, physicians education, multi-strategy examinations, and facilitated appointments. Taking 
into account the limitations of the included secondary analyses, a high-quality comprehensive review 
of relationships between indicators of socio-economic determinants and screening uptake, comparing 
the possible differences among jurisdictions, will be an asset to conclude on the raised contradictions. 
Fourthly, our study revealed differences between reviews related to definitions used which could lead 
to possible confusion in terminology, for example between participation rate and attendance19,22,27,32.  
Such inconsistencies in measures and definitions of screening participation are common in reviews of 
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other cancer screening programs 10.  The definitions of the European guidelines for quality assurance 
in BCS and diagnosis for participation rate, coverage by invitation, and coverage by screening 
15 should be reinforced to follow globally, to avoid confusion in the assessment, reporting and inter-
pretation of BCS participation.  
Study limitations 
Given the large scope of this systematic review of reviews, we may have missed some of the literature 
related to the topic, despite the attempt to identify all relevant data.  We also note the limitations of 
using AMSTAR for judging the quality of the reviews on screening participation rate; for example, 
the questions on data synthesis used in AMSTAR may not be directly relevant for reviews of non-
clinical outcomes. Furthermore, the reviews could have other limitations not highlighted by AM-
STAR, such as incorrect or unclear reporting of the target outcome. As such, a high quality score on 
AMSTAR may not mean an absence of bias in the systematic reviews that were evaluated. 
Clinical policy implications 
Since implementation of BCS programs has already stimulated multiple discussions about their bene-
fit/harm ratio and cost-effectiveness 46,47, understanding how much support these programs gain from 
various groups, such as the medical community and the women themselves, can be an important pa-
rameter defining the programs priority on the political agenda. This is especially crucial for countries 
considering implementation of a population-wide screening program, re-assessing continuation of the 
existing program, or evaluating screening extension to other age groups. Moreover, knowledge of the 
determinants of BCS participation would help to design programs receiving higher acceptance from the 
affected groups, and could improve implementation outcomes. As suggested by this study, developing 
policies such as scheduling fixed appointments while inviting the women to screening, or requesting 
that medical providers prompt women regarding screening mammograms, can boost participation rates. 
Besides, simple population-oriented strategies, and system and structural interventions are effective to 
increase participation in mammography screening and should be considered by program commission-
ers.   
Conclusions 
While systematic reviews are perceived as a lens of evidence, their results are not always con-
sistent. Policy makers should prioritise the interventions consistently reported as effective in second-
ary research, and critically assess applicability of the review findings to the local context.  
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Figures 
Figure 1. PRISMA 2009 Flow Diagram used for breast cancer screening review. *Supplementary 
search. See Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Re-
porting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): 
e1000097. doi:10.1371/journal.pmed1000097 
 
Figure 2. Quality of systematic reviews graded by AMSTAR criteria. 
 
Figure 3. The Systems Model of Clinical Preventive Care by Walsh and McPhee. (1) Outcomes are 
defined as decreased disease incidence, decreased morbidity, and decreased mortality. (2) Predispos-
ing factors relate to the motivation to perform a particular health behavior. (3) Enabling factors: in-
clude the skills and resources necessary to perform the behavior. (4) Reinforcing factors are those that 
support or reward the behavior.  (5) Health care delivery system/organizational factors include access 
to care; availability of technology and personnel; organizational priorities; structure of office practice; 
reimbursement; and coordination with community resources. (6) Preventive activity factors are fea-
tures of the preventive activity itself and include costs; risks; efficacy; and effectiveness. (7) Situa-
tional factors/cues to action are triggers to health behavior and include internal cues, such as symp-
toms and external cues such as physician reminders. Reproduced with permission from Walsh JM, 
McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and 
physician. Health Educ Q 1992; 19: 157175. 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For more information, visit www.prisma-statement.org. 
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Table 1. Factors with a consistent direction of effect on participation rate in breast cancer screening 
Factors Direction of effect Frequency or reporting / Source 
Patient predisposing factors 
Intentions to screening Positive 2 reviews (14, 15)  
Patient Enabling Factors 
Removal of financial barriers Positive 4 reviews (14, 15, 22, 29) vs 1 unclear 
effect (20) 
Simple letters or calls Positive 6 reviews (8, 14, 19, 22, 29,  33) 
Tailoring by ethnicity  No or limited effect 1 review (33) 
Word of mouth  Positive 1 review (31) 
Recommendation/support by a healthcare provider Positive 3 reviews (14, 19, 33)  
Small  media Positive 1 review (20) 
Big media/social networks No or limited effect 3 reviews (13, 20, 34)  
Extensive written or verbal health education  
vs brief recommendations 
No or limited effect 3 reviews (13, 18, 22) 
Telephone counselling Positive 4 reviews (8, 14, 28, 29) 
Home visits vs no visits Positive 2 reviews (14, 29) 
Home visits vs simple invitation  No or limited effect 2 reviews (8, 13) 
Individual education  Positive 4 reviews (18, 20, 22, 28)  
Health care delivery system/ organizational factors 
Organizational features of a healthcare system  Positive 1 review  (29)  
Opportunistic screening or low coverage rate  Positive 2 reviews (14, 29)  
Health insurance  Positive 
2 reviews  (14, 24) 
Structural reorganizations  Positive 3 reviews (14, 20, 22) 
Management systems Positive 3 reviews (14, 20, 22) 
Mobile MM or community screening  Positive 3 reviews (14, 25, 32)   
Test / Preventive Activity Factors 
Previous MM   Positive or negative 4 reviews (1416, 35) 
Situational factors / cues to action 
Risk-factor questionnaires No or limited effect 2 reviews (14, 26) 
Fixed appointment with any invitation approach Positive 4 reviews  (13, 14, 18, 22) 
Reminder letters or invitation follow-ups  Positive  8 reviews (8, 13, 14, 18-19, 22, 28) vs 
1 unclear effect (20) 
Phone reminders No or limited effect 1 review (13) 
Endorsement by GP No or limited effect 1 review (13) 
Second mailed Positive 1 review (34)  
Providers prompts  Positive  4 reviews (14, 18, 19, 28)  
 Information received from family or friends; 
 Before intervention 
The Legend: Abbreviations: BC  breast cancer; BCS  breast cancer screening; GP  general practitioner; MM  screening mammography 
Table 2. Factors with unclear or undefined effect on participation rate in BCS 
Factors Level of disagreement    Source 
Patient predisposing factors 
Medical history,  
Other preventive behaviour,  
Self-beliefs and worries,  
Demographic factors  
Inconsistent in reviews 14,15,35;  
14,15;  
14,15,24,29; 
14,15,21,23,24,28  
Patient Enabling Factors 
Knowledge of BC and/or BCS Inconsistent in reviews 14,15,32 
Tailoring vs. personalized invitation Unclear original evidence  18,22 
Public information campaigns  Unclear original evidence 18,20 
Face-to-face counselling Inconsistent in reviews 14,18,20,22,36  
Printed information materials in addition to 
standard invitation 
 
Unclear original evidence ((14, 18, 20, 
34) and inconsistent in reviews 
8,14,18,20,34  
Academic detailing or use of theory  Unclear original evidence 22,28 
Group education Unclear original evidence 20 
Patient reinforcing factors 
Rewards or incentives to patients Unclear original evidence (18,20,34) and 
inconsistent in reviews 
14,18,20,34 
Provider reinforcing factors 
Rewards or incentives to providers  Unclear original evidence 20 
Physician Enabling Factors 
Physician education Inconsistent in reviews 14,22 
Health care delivery system/ organizational factors 
Settings and screening approaches (ex. 
intervals) 
Unclear original evidence 28  
Multistrategy examinations Inconsistent in reviews 8,13,14,28  
Reduction of logistical barriers /transport 
access 
Unclear original evidence (13) and 
inconsistent in reviews 
13,15 
Facilitated appointment schedule Inconsistent in reviews 15,22 
Situational factors / cues to action 
Face-to-face reminder Unclear original evidence 18,20 
 
 
 
